Femasys Inc. to Participate in Upcoming January Investor Conferences
23 déc. 2021 08h05 HE
|
Femasys Inc.
ATLANTA, Dec. 23, 2021 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a biomedical company aiming to meet women's needs worldwide by developing a suite of product candidates that include minimally...
Femasys Inc. Announces Financial Results for the Third Quarter of 2021
10 nov. 2021 16h05 HE
|
Femasys Inc.
-- Up to 792-patient, pivotal LOCAL trial progressing for FemaSeed® after receipt of investigational device exemption (IDE) submission approval -- -- Femasys added to the Russell...
Femasys Inc. to Present at The MedTech Conference
23 sept. 2021 17h46 HE
|
Femasys Inc.
ATLANTA, Sept. 23, 2021 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a biomedical company aiming to meet women's needs worldwide by developing a suite of product candidates that include...
Femasys Inc. To Join the Russell Microcap® Index
20 sept. 2021 16h05 HE
|
Femasys Inc.
ATLANTA, Sept. 20, 2021 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY) (“Femasys” or the “Company”), a biomedical company developing a suite of product candidates to transform women’s healthcare...
Femasys Inc. Announces the Appointment of Edward Evantash, M.D. as Chief Medical Officer
01 sept. 2021 16h05 HE
|
Femasys Inc.
-- Industry veteran with over than two decades of experience in medical affairs to lead clinical and medical affairs at Femasys -- ATLANTA, Sept. 01, 2021 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ:...
Femasys Inc. Announces Financial Results for the Second Quarter of 2021
11 août 2021 16h05 HE
|
Femasys Inc.
Completed initial public offering (“IPO”) raising net proceeds of $31.6 millionAppointed Anne Morrissey to the Board of Directors, an industry expert with decades of medical device experienceInitiated...
Femasys Inc. Announces First Patient Treated in Pivotal Trial for FemaSeed
20 juil. 2021 08h31 HE
|
Femasys Inc.
First in Class Insemination Treatment for Infertility LOCAL Pivotal Trial to Enroll Up to 792 Patients Across 20 U.S. Centers ATLANTA, July 20, 2021 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ:...
Femasys Inc. Announces Appointment of New Board Member
24 juin 2021 10h54 HE
|
Femasys Inc.
ATLANTA, June 24, 2021 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a biomedical company focused on transforming women's healthcare, today announced the appointment of Anne Morrissey to the...
Femasys Inc. Announces Pricing of Initial Public Offering
17 juin 2021 20h00 HE
|
Femasys Inc.
ATLANTA, June 17, 2021 (GLOBE NEWSWIRE) -- Femasys Inc., a biomedical company focused on transforming women's healthcare by developing novel solutions and next-generation advancements providing...
Femasys Announces First 100 Women Treated in Pivotal Clinical Trial with FemBloc® Permanent Contraceptive System
04 janv. 2019 09h13 HE
|
Femasys Inc.
ATLANTA, Jan. 04, 2019 (GLOBE NEWSWIRE) -- Femasys, Inc., a medical technology company developing a platform of innovative in-office solutions for women’s healthcare today announced that the first...